Just two weeks ago, a deal was struck that has the potential to totally reshape a key tech sector. The most important tech company that nobody has ever heard of is joining forces with one of the fastest growing firms in the sector.
To get an idea of just how important this unknown player is, you probably use their tech every day before you even have breakfast in the device you use to set your alarm, and the internet router you use to check the morning news.
The brand defining devices made by Apple Inc. (AAPL) all rely on this company’s tech. That’s why this deal is going to change the entire tech sector.
How the tech works is complicated, but how they can make you money isn’t.
Chris Giattina is working with a top-flight software platform to transform the nation’s $3.6 trillion healthcare system.
And no, he’s not pioneering a breakthrough in genetics a or cutting-edge new drug.
His approach is a bit more basic. But in these COVID challenging times, his work is very important, not to mention profitable for savvy tech investors who know where to look.
Here’s the thing. Giattina is the CEO of BLOX, which is focusing heavily on making modular medical facilities.
Using its unique approach to construction, BLOX can have a 16-bed isolation unit ready for patient use in as little as a week.
That could prove a huge benefit in the continuing war on COVID. See, some cities and towns have found themselves short of medical facilities when there is a spike in new cases.
Given that BLOX is privately held, there is no direct way to invest in this disruptive tech, but you still have the chance to make money off of their disruptive building tech.
I get the appeal of IPOs. Who wouldn’t want to say they invested Amazon.com Inc. (AMZN) or Apple Inc. (APPL) when they first went public?
Well, over the next few months, there’s going to be a lot of hype about Ant Group, which if it hits analysts” expectations, could be the biggest IPO ever at $30 billion.
Of course, there’s a catch – shares will be listed in Hong Kong and Shanghai, making the Ant IPO out of reach for most U.S. investors.
However, I have a way to own shares of Ant without having to set up an international brokerage account or paying excessive fees to invest in foreign stocks.
Best of all, it’s a move you can make BEFORE the IPO.
After contracting COVID-19 last May, he was hospitalized with severe respiratory issues and multiorgan failure.
And if that wasn’t bad enough, the 42-year Pennsylvania warehouse worker also had to deal with a malfunctioning heart. That alone could have killed him.
But doctors at the Mercy Catholic Medical Center in Pennsylvania were able to save Smith in no small measure because of a tiny heart pump.
Known as the Impella, that device received an emergency use authorization from the FDA to treat coronavirus patients only weeks before.
Of course, Smith credits the medical team with saving his life. But he’s quick to point out that the Impella played a big role in it all.
And Bill is not alone.
These kinds of heart complications are reported to affect as many as 10% of COVID-19 patients.
Fortunately for tech investors, there’s a lot more going on here than a feel-good feature story.
The medical device market is worth $625 billion, and the company behind Impella can grab a big chunk of that.
COVID-19 has proven what I’ve been seeing for the past decade: the entire economy is the tech economy. You may not think that retailers like Walmart Inc. (WMT) and Target Inc. (TGT) are tech companies, but they have been boosting their revenue this past quarter on the back of multiplying e-commerce sales. It just goes to show that not only do leading tech innovators drive growth in the market, but any company, no matter what they do, can give themselves a much-needed edge by keeping up with the times. Add in the fact that growth investors, largely fueled by tech, have made more money in ten years than value investors have in thirty, and its plain to see that the road to wealth is paved with tech. There are plenty of opportunities approaching in the era of all things digital. Click to watch!
Several high-profile Wall Street personalities have drawn attention lately for investing in Bitcoin – most notably billionaire hedge fund manager Paul Tudor Jones.
But one investing legend was buying Bitcoin years before it became fashionable: Veteran fund manager Bill Miller.
Miller built his reputation as co-manager of Legg Mason’s Capital Management Value Trust fund in the 1990s and the early 2000s. His best-known achievement was beating the S&P 500 for 15 years straight, from 1991 to 2005.
When Miller first bought Bitcoin way back in 2014, it caught many by surprise. While his definition of “value” was broader than most – he was buying tech stocks like America Online and Dell Computer in the early 1990s – cryptocurrency was literally in a class by itself.
Many investing experts in 2014 were deriding Bitcoin as a “Ponzi scheme” devoid of any real value. Warren Buffett called it a “mirage.” Predictions Bitcoin would go to zero were common.
Apple is on the verge of marking another milestone for the history books. It is quickly closing in on a $2-trillion market value.
Just think about that for a moment…
If you’re anything like me, then you’ve lost count of the times over the last couple of years that the so-called “experts” said Apple was “overpriced” and set to go into the tank.
It seems like only yesterday that a talking car was strictly science fiction.
You see, as a Boomer of a “certain age,” I vividly recall the 1980s hit TV series “Knight Rider.”
The show featured a 1982 Pontiac Firebird laden with advanced tech systems like artificial intelligence. And of course, the ability to talk with the driver.
Now, more than 32 years after the show ended, this pop-culture icon lives on because of online streaming.
Of course, these talking cars are pretty routine in no small measure than owners often use their smartphones for voice control navigation.
Now comes “talking” highways. Utah and Georgia are experimenting with tech that allows highways to communicate with cars about congestion and road hazards.
None of this would be possible without one of the unsung heroes of high tech -sensors.
With COVID-19 dominating the news cycle, it is no wonder that biotech is front and center in people’s minds. Almost every day, we see news from companies like Moderna Inc. (MRNA), Gilead Sciences Inc. (GILD), Sorrento Therapeutics Inc. (SRNE), and many other companies racing to create a vaccine.
Miller built his reputation as co-manager of Legg Mason’s Capital Management Value Trust fund in the 1990s and the early 2000s. His best-known achievement was beating the S&P 500 for 15 years straight, from 1991 to 2005.